Company profile

ArteraAI Tech Stack

AI-enabled prognostic and predictive tests for cancer therapy decisions

Hospitals and Health Care Los Altos, California 51–200 employees Privately Held

ArteraAI builds AI biomarker tests that guide treatment choices in oncology, starting with localized prostate cancer. Its stack pairs a deep ML orchestration layer (PyTorch, JAX, Ray, Kubeflow, Flyte, DeepSpeed, DINOv2) with a heavily customized Salesforce build (Apex, LWC, Salesforce DX). Sales-led hiring plus a CMO search and billing-automation projects point to a commercial push focused on reimbursement, payer adoption and expansion into breast cancer diagnostics.

Tech Stack 42 technologies

Core StackSalesforce Apex Python PyTorch TensorFlow Kubeflow MLflow Dagster Prefect AWS Docker Kubernetes Terraform Lightning Web Components Salesforce DX R Markdown Flyte Ray Metaflow Argo Workflows JAX SQLAlchemy TorchScript ONNX Runtime DeepSpeed AWS Neuron DINOv2 tidyverse GCP Azure+12 more

What ArteraAI Is BuildingChallenges and projects from their job posts

◆Challenges

Ensuring payer adoption of AI tests
Regulatory submissions and shifting reimbursement rules
Complex billing operations across multiple vendors
Evidence gaps in breast cancer diagnostics
Underperforming distributor partners
Identifying unmet clinical needs

▲Active Projects

AI-driven billing pipeline with Salesforce automation
Clinical evidence generation, including breast cancer strategy
AI model validation through clinical studies
High-quality clinical data pipeline development
Clinical study design and execution
Regulatory submission support

Hiring Activity

Steady10 roles · 3 in 30d

Department

Sales

Engineering

Research

Healthcare

Seniority

Senior

Director

C-Level

Junior

Mid

Notable leadership hires: Chief Medical Officer, Scientific Director, Sales Director

Companies like ArteraAI

400+ Hospitals and Health Care companies running Salesforce and Python

See the full list

About ArteraAI

ArteraAI is a privately held precision medicine company headquartered in Los Altos, California, with 51–200 employees. It develops AI-based tests that estimate patient outcomes and help personalize therapy for cancer patients, with its initial focus on localized prostate cancer. Its biomarkers were developed using data from Phase III randomized trials. The company sells to clinicians and works with payers and distributor partners on adoption. It hires in the United States and Bulgaria across sales, engineering, research and clinical functions.

HeadquartersLos Altos, California

Company Size51–200 employees

Hiring MarketsUnited States, Bulgaria

Frequently Asked Questions

What tech stack does ArteraAI use?

ArteraAI uses Python, PyTorch, TensorFlow, JAX, Ray, Kubeflow, Flyte, MLflow and Dagster for ML, runs on AWS with Docker, Kubernetes and Terraform, and builds on Salesforce with Apex and Lightning Web Components.

Is ArteraAI hiring?

Yes, hiring is steady and sales-led, with additional engineering, research and healthcare roles. Leadership openings include Chief Medical Officer, Scientific Director and Sales Director, in the United States and Bulgaria.

What is ArteraAI working on?

Current projects include clinical evidence generation, an AI-driven billing pipeline, automated billing workflows in Salesforce, AI model validation, clinical data pipelines and an evidence strategy for breast cancer diagnostics.

Similar Companies in Hospitals and Health Care

Other companies in the same industry, closest in size

Trella Health

Hospitals and Health Care

Artisight

Hospitals and Health Care

Droxi

Hospitals and Health Care

CARPL - Radiology AI Platform

Hospitals and Health Care

How this profile is built

ArteraAI's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.